{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:13:59Z","timestamp":1792120439957,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.celrep.2024.113831","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T22:33:59Z","timestamp":1708727639000},"page":"113831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity"],"prefix":"10.1016","volume":"43","author":[{"given":"Tirta M.","family":"Djajawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizzy","family":"Pijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Srivaths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chisanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Fei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarahi Mendoza","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Bartonicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry C.C.","family":"Lim Kam Sian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Behren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephin J.","family":"Vervoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky W.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor J.","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.113831_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T\u00a0cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.113831_bib2","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.celrep.2024.113831_bib3","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.celrep.2024.113831_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary Resistance to PD-1 Blockade Mediated by JAK1\/2 Mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2024.113831_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3451","article-title":"Tumor immune evasion arises through loss of TNF sensitivity","volume":"3","author":"Kearney","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2024.113831_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In\u00a0vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.113831_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T\u00a0cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.113831_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.trecan.2020.02.003","article-title":"Cancer Epigenetics, Tumor Immunity, and Immunotherapy","volume":"6","author":"Cao","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.celrep.2024.113831_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2024.113831_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2024.113831_bib11","article-title":"Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.113831_bib12","article-title":"Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2024.113831_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04381-5","article-title":"PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2024.113831_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2024.113831_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110582","article-title":"PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade","volume":"38","author":"Srour","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.113831_bib16","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-023-38443-3","article-title":"PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.113831_bib17","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","article-title":"Pharmacologic modulation of RNA splicing enhances anti-tumor immunity","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.113831_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41416-023-02276-0","article-title":"Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors","volume":"129","author":"El-Khoueiry","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2024.113831_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2024.113831_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.113831_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/2326-6066.CIR-21-0543","article-title":"Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity","volume":"9","author":"Hu","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2024.113831_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.113831_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107576","article-title":"SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics","volume":"14","author":"Lim Kam Sian","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.113831_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/0008-5472.CAN-23-1082","article-title":"PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma","volume":"84","author":"Tao","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.celrep.2024.113831_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41589-022-01024-4","article-title":"PRMT inhibition induces a viral mimicry response in triple-negative breast cancer","volume":"18","author":"Wu","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2024.113831_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2020.12.031","article-title":"Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer","volume":"184","author":"Bowling","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.113831_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pcmr.12097","article-title":"The Ludwig institute for cancer research Melbourne melanoma cell line panel","volume":"26","author":"Behren","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.celrep.2024.113831_bib28","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/s41598-022-06841-0","article-title":"Survival Genie, a web platform for survival analysis across pediatric and adult cancers","volume":"12","author":"Dwivedi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2024.113831_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw087","article-title":"gEVE: a genome-based endogenous viral element database provides comprehensive viral protein-coding sequences in mammalian genomes","volume":"2016","author":"Nakagawa","year":"2016","journal-title":"Database"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:24:21Z","timestamp":1741332261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2211124724001591"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.113831","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.113831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"113831"}}